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Abstract
Background/Aims: In humans and rodents, organic anion transporter 3 (Oat3) is highly
expressed on the basolateral membrane of renal proximal tubules and mediates the secretion
of exogenous and endogenous anions. Regulation of Oat3 expression and function has
been observed in both expression system and intact renal epithelia. However, information
on the local membrane environment of Oat3 and its role is limited. Lipid raft domains (LRD;
cholesterol-rich domains of the plasma membrane) play important roles in membrane protein
expression, function and targeting. In the present study, we have examined the role of LRDrich
membranes and their associated cytoskeletal proteins on Oat3 expression and function.
Methods: LRD-rich membranes were isolated from rat renal cortical tissues and from HEK-293
cells stably expressing human OAT3 (hOAT3) by differential centrifugation with triton X-100
extraction. Western blots were subsequently analyzed to determine protein expression. In
addition, the effect of disruption of LRD-rich membranes was examined on functional Oat3
mediated estrone sulfate (ES) transport in rat renal cortical slices. Cytoskeleton disruptors
were investigated in both hOAT3 expressing HEK-293 cells and rat renal cortical slices. Results:
Lipid-enriched membranes from rat renal cortical tissues and hOAT3-expressing HEK-293 cells
showed co-expression of rOat3/hOAT3 and several lipid raft-associated proteins, specifically
caveolin 1 (Cav1), β-actin and myosin. Moreover, immunohistochemistry in hOAT3-expressing
HEK-293 cells demonstrated that these LRD-rich proteins co-localized with hOAT3. Potassium
iodide (KI), an inhibitor of protein-cytoskeletal interaction, effectively detached cytoskeleton
proteins and hOAT3 from plasma membrane, leading to redistribution of hOAT3 into non-LRDrich
compartments. In addition, inhibition of cytoskeleton integrity and membrane trafficking
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Abstract
Background/Aims: In humans and rodents, organic anion transporter 3 (Oat3) is highly 
expressed on the basolateral membrane of renal proximal tubules and mediates the secretion 
of exogenous and endogenous anions. Regulation of Oat3 expression and function has 
been observed in both expression system and intact renal epithelia. However, information 
on the local membrane environment of Oat3 and its role is limited. Lipid raft domains (LRD; 
cholesterol-rich domains of the plasma membrane) play important roles in membrane protein 
expression, function and targeting. In the present study, we have examined the role of LRD-
rich membranes and their associated cytoskeletal proteins on Oat3 expression and function. 
Methods: LRD-rich membranes were isolated from rat renal cortical tissues and from HEK-293 
cells stably expressing human OAT3 (hOAT3) by differential centrifugation with triton X-100 
extraction. Western blots were subsequently analyzed to determine protein expression. In 
addition, the effect of disruption of LRD-rich membranes was examined on functional Oat3 
mediated estrone sulfate (ES) transport in rat renal cortical slices. Cytoskeleton disruptors 
were investigated in both hOAT3 expressing HEK-293 cells and rat renal cortical slices. Results: 
Lipid-enriched membranes from rat renal cortical tissues and hOAT3-expressing HEK-293 cells 
showed co-expression of rOat3/hOAT3 and several lipid raft-associated proteins, specifically 
caveolin 1 (Cav1), β-actin and myosin. Moreover, immunohistochemistry in hOAT3-expressing 
HEK-293 cells demonstrated that these LRD-rich proteins co-localized with hOAT3. Potassium 
iodide (KI), an inhibitor of protein-cytoskeletal interaction, effectively detached cytoskeleton 
proteins and hOAT3 from plasma membrane, leading to redistribution of hOAT3 into non-LRD-
rich compartments. In addition, inhibition of cytoskeleton integrity and membrane trafficking 
D
ow
nl
oa
de
d 
by
: 
A
pp
al
ac
hi
an
 S
ta
te
 U
ni
ve
rs
ity
19
8.
86
.8
.2
 -
 4
/2
2/
20
16
 3
:1
9:
38
 P
M
Cell Physiol Biochem 2013;31:565-578
DOI: 10.1159/000350077
Published online: April 26, 2013
© 2013 S. Karger AG, Basel
www.karger.com/cpb 566
Srimaroeng et al.: Lipid Raft Domains Regulate Oat3 Expression and Function
Cellular Physiology 
and Biochemistry
processes significantly reduced ES uptake mediated by both human and rat Oat3. Cholesterol 
depletion by methyl-β-cyclodextrin (MβCD) also led to a dose dependent reduction Oat3 
expression and ES transport by rat renal cortical slices. Moreover, the up-regulation of rOat3-
mediated transport seen following insulin stimulation was completely prevented by MβCD. 
Conclusion: We have demonstrated that renal Oat3 resides in LRD-rich membranes in proximity 
to cytoskeletal and signaling proteins. Disruption of LRD-rich membranes by cholesterol-
binding agents or protein trafficking inhibitors altered Oat3 expression and regulation. These 
findings indicate that the integrity of LRD-rich membranes and their associated proteins are 
essential for Oat3 expression and function. 
Introduction
Lipid raft domains (LRD) serve as platforms for cell surface signal transduction and 
protein targeting, regulation of membrane protein function, and modulation of cholesterol 
homeostasis [1, 2]. Caveolin (Cav), a structural protein component of caveolar-type lipid raft 
domains was shown to play functional roles in several cellular processes, including vesicular 
transport, cholesterol homeostasis, tumor suppression and intracellular signal transduction 
[1, 3, 4]. Several pathogens and toxins utilize caveolar endocytosis as a pathway to enter 
the host cells [1, 4]. Caveolin 1 (Cav1) is tightly bound to cholesterol and helps to regulate 
intracellular cholesterol concentration [5-7], and caveolar rafts serve as platforms for 
compartmentalization of signaling molecules, including muscarinic receptor associated Ca2+ 
signaling [8] and glucagon-like peptide stimulated extracellular signal regulated kinase 1 
and 2 (ERK1/2) activation [9]. Recently, proteomic analysis also revealed a specific role for 
macrophage rafts in compartmentalization and regulation of the mitogen-activated protein 
kinase (MEK-ERK) signaling pathway [10]. In addition, cytoskeletal elements, including 
actin, tubulin, myosin, actinin and supervillin, have been shown to be enriched in LRD [11]. 
Here, they have been shown to be essential for the structural and functional characteristics 
of LRD. For example, depolymerization of microtubules by nocodazole attenuated Cav1 
vesicle movement between the cell surface and specific endosomal compartments. Moreover, 
disruption of the actin cytoskeleton by latrunculin A resulted in extensive movement of 
intracellular Cav1 vesicles toward the microtubule containing centrosome [12]. Similarly, 
in Jurkat cells, co-treatment with the cholesterol binding agent, filipin, and the actin 
cytoskeleton disruptor, latrunculin B, interfered with co-clustering of raft-associated 
proteins and signaling cascade of the Src family of tyrosine kinases [13]. Thus, the function 
and regulation of other membrane proteins may be modulated via the integrity of LRD and 
their associated proteins. These include transporters. For instance, glycine transporter 1 
(GLY1) was localized in a cholesterol-rich membrane domains of the Chinese hamster ovary 
K1 (CHO-K1) cells and the rate of glycine transport mediated by GLY1 was highly sensitive 
to membrane rafts integrity [14]. In renal epithelial cells, Na+-H+ exchanger 3 (NHE3) and 
Na+-K+-ATPase (NKA) were shown to associate with LRD and their functions were attenuated 
by cholesterol depletion [15, 16]. Moreover, organic anion transporter 1 (Oat1) and Cav2 
were shown to co-localize in renal primary culture cells; whereas, Oat3 was co-expressed 
with Cav1. Decreasing expression of either Cav1 or Cav2 led to a reduction of Oat1 or Oat3 
function [17, 18]. This study addressed protein-protein interactions and did not investigate 
the role of the caveolar-type lipid rafts in Oat1 and Oat3 function. Therefore, we examined 
the hypothesis that changes in LRD-rich membrane composition, induced by cellular 
membrane cholesterol content interference or by cytoskeletal proteins disruption may affect 
Oat3 expression and function, and lead to changes in the pharmacokinetics of the substrates, 
including drugs and xenobiotics.
This study is focused on the regulation and function of renal Oat3. As the most highly 
expressed OAT in human renal epithelial cells [19], Oat3 has been shown to play an important 
 Copyright © 2013 S. Karger AG, Basel
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role in handling a broad variety of endogenous metabolites, drugs, and xenobiotics including 
prostaglandin E2 and F2α, adrenaline, serotonin, antibiotics, antivirals, anti-epileptics, anti-
neoplastics, non-steroidal anti-inflammatory drugs and ochratoxin A [20-23]. An Oat3 
knock-out mouse model has conclusively demonstrated that Oat3 also mediates transport 
of organic anions in liver and choroid plexus [24-27]. Thus, it is positioned to have a major 
impact on distribution and elimination of drugs and toxins in both barrier and excretory 
tissues. In addition, Oat3 was also regulated by several compounds. For instance, the PKC 
activator, phorbol-12-myristate-13-acetate (PMA), down-regulated Oat1 and Oat3 function 
through decreased expression of Oat1 and Oat3 at the plasma membrane [28, 29]. In 
contrast, insulin and epidermal growth factor (EGF) stimulated Oat1 and Oat3 function via 
increasing their expression at the plasma membrane [30]. In this study, we have 1) assessed 
the role of LRD-rich membranes and their associated proteins on expression and function 
of Oat3, 2) examined the association of LRD-rich membrane and Oat3 in human embryonic 
kidney 293 (HEK-293) cells stably expressing hOAT3 and rat renal cortical tissues, and 3) 
examined the impact of pharmacological manipulation of LRD-rich membrane integrity and 
Oat3 expression and function.
Materials and Methods
Chemicals
Polyclonal rabbit anti-rOat3 antibody was obtained from Cosmobio (Tokyo, Japan). Monoclonal 
mouse anti-β actin was purchased from Abcam (Cambridge, MA). Monoclonal anti-caveolin1 was purchased 
from Calbiochem (Billerica, MA). Polyclonal anti-myosin was purchased from Biomedical Technologies 
(Stoughton, MA). Anti-V5 and Alexa Fluor 488 goat anti-mouse and rabbit antibodies were obtained from 
Invitrogen (Carlsbad, CA). Human recombinant insulin, glutarate, methyl-beta-cyclodextrin (MβCD), 
alpha-cyclodextrin (α-CD), cycloheximide, brefeldin A (BFA), latrunculin A, okadaic acid and CelLytic™ MT 
mammalian tissue lysis/extraction reagent were obtained from Sigma Aldrich (St. Louis, MO). Complete 
protease inhibitor cocktail was purchased from Roche Applied Science (Indianapolis, IN). Tritiated estrone 
sulfate ([3H]-ES; specific activity (SA) 50 Ci/mmol) was obtained from PerkinElmer Life Sciences (Boston, 
MA). Tetra-ethylammonium bromide ([14C]-TEA; SA 55 mCi/mmol) and 1-methyl-4-phenylpyridinium 
([3H]-MPP+; SA 1 mCi/mmol) were obtained from American Radiolabled Chemicals (St. Louis, MO). All other 
chemicals were purchased from commercial sources at the highest purity available.
Animals
Adult male Sprague Dawley rats were euthanized by either CO2 or pentobarbital followed by 
decapitation according to protocols approved by the National Institute of Environmental Health Sciences 
(NIEHS) and Chiang Mai University Animal Care and Use Committees. Kidneys were excised and placed 
in oxygenated saline buffer for experimental use. Animals were given standard pelleted chow and water 
ad libitum and maintained on a 12-hrs light/dark cycle. The animals were fasted overnight prior to tissue 
harvest. 
Detergent extraction of cell membranes 
Renal cortical slices (≤0.5 mm; 5 – 15 mg, wet weight) were cut with a Stadie-Riggs microtome. To 
increase yields of the fractions, LRD-rich and non-LRD-rich membrane fractions were then prepared using 
a modification of the method previously described by Lockwich et al. [8]. Briefly, slices were suspended 
in CelLytic™ MT mammalian tissue lysis/extraction reagent containing 1% protease inhibitor according 
to the manufacturer’s protocol. Tissues were then homogenized and centrifuged at 2,500 g for 10 min at 
4°C and supernatant was re-suspended in a sucrose buffer containing (mM): 250 sucrose, 10 Tris-HEPES 
(pH.7.4), 1 DTT, and 1% protease inhibitor. The homogenate was centrifuged at 3,000 g for 15 min at 4°C. 
The supernatant was then centrifuged at 50,000 g for 30 min at 4°C. The supernatant fraction from this 
spin was designated as the cytoplasmic fraction (C). The crude membrane pellets were re-suspended in 
a sucrose buffer and extracted for 1 hr at 4°C in a lysis buffer containing (mM): 50 Tris-HCl (pH.7.5), 150 
NaCl, 5 EDTA and 1% triton X-100 (v/v). Samples were then centrifuged at 4°C for 1 hr 30 min at 100,000 g. 
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The supernatant fraction was designated as the soluble, or non-LRD-rich, fraction (S). The pellets were re-
suspended in the lysis buffer and designated as the insoluble fraction (I), or LRD-rich fraction. All samples 
(C, S, I) were stored at –80°C prior to use. 
A HEK-293 cell line stably expressing hOAT3 with a V5 tag was generated previously [31] using pEF/
FRT/V5-DEST vector. LRD-rich membranes were isolated from these cells using a modification of the 
method previously described by Lockwich et al. [8]. Cells were washed two times with cold phosphate-
buffered saline (PBS) and suspended in CelLytic™ MT mammalian tissue lysis/extraction reagent containing 
1% protease inhibitor. Cells were then homogenized and centrifuged at 250 g for 10 min at 4°C and the 
supernatant was re-suspended in a sucrose buffer and extracted for 1 hr at 4°C in a lysis buffer containing 
(mM): 50 Tris-HCl (pH.7.5), 150 NaCl, 5 EDTA and 1% triton X-100 (v/v). To disrupt cytoskeleton protein 
interactions, 1 M KI was added to the lysis buffer in this step. Samples were then centrifuged at 4°C for 1 hr 
30 min at 100,000 g and all fractions (C, S, I) were obtained as described above. 
Immunostaining
Wild type (WT) and HEK-293 cells transfected with hOAT3-V5 tag were seeded on poly-D-lysine 
coated slides at a concentration of 1x105 cells/well and grown for 48 hrs at 37°C. Cells were then washed 
3 times in Tris-buffered saline (TBS) and fixed in 3.8% formaldehyde for 10 min. Subsequently, cells were 
washed in TBS 3 times and permeabilized with 0.1% triton X-100 for 1 min. Cells were washed again for 
3 times with TBS and incubated with blocker BSA (Pierce, Rockford, IL) for 30 min. Primary antibodies 
(see figure legends) were applied for 1 hr. Cells were then washed 3 times with TBS and incubated with a 
corresponding secondary antibody (Molecular Probes, Carlsbad, CA) for 1 hr and again washed 3 times with 
TBS. Images were taken with Argon ion 488 nm and HeNe 543 nm excitation using laser scanning confocal 
microscopy (Zeiss 510 NLO, Thornwood, NY).
Western Blot analysis
Protein content was measured using the Bradford assay (Biorad, Hercules, CA). For each sample, 50 µg 
were heated in 4X NuPAGE® LDS sample buffer (Invitrogen, Carlsbad, CA) for 10 min. Invitrogen NuPAGE® 
Novex Bis-tris or 7% polyacrylamide gel was electrophoresed on an Invitrogen XCell Surelock (Grand 
Island, NY) or a Biorad apparatus (Hercules, CA). Polyvinylidene difluoride membranes were blocked for 
1 hr with Pierce Starting Block PBS buffer (Rockford, IL) at 4°C and incubated overnight with a specific 
primary antibody (see figure legends). Membranes were washed with PBS-tween and incubated with 
a corresponding secondary antibody for 1 hr at 4°C. Supersignal West Pico chemiluminescent substrate 
(Pierce, Rockford, IL) was used to detect bands with a Gel doc XR system (Biorad, Hercules, CA). 
Renal slice preparation and uptake study 
After the rat kidneys were removed and placed in oxygenated saline buffer, renal cortical slices (≤0.5 
mm; 5–15 mg, wet weight) were cut with a Stadie-Riggs microtome and maintained in ice-cold oxygenated 
modified Cross and Taggart buffer containing (mM): 95 NaCl, 80 mannitol, 5 KCl, 0.74 CaCl2 and 9.5 Na2HPO4, 
pH 7.4). The slices were pre-incubated in 1 ml of buffer in the absence or presence of test compounds (see 
figure legends) for 30 min and then incubated in 1 ml of buffer containing either 100 nM [3H]-ES, 10 µM 
[14C]-TEA or 1.25 nM [3H]-MPP+ for 30 min. Uptake was stopped by the addition of ice-cold buffer. Slices were 
washed, blotted, weighed, dissolved in 1 ml of 1 N NaOH and neutralized with 1 ml of 1 N HCl. Scintillation 
fluid of 15 ml was added and the radioactivity was measured using a Liquid Scintillation Analyzer (Packard, 
Meriden CT, USA). Uptake of radiolabeled substrate was calculated as tissue to medium (T/M) ratio, i.e., 
(DPM/g tissue)/(DPM ml medium). 
Measurement of estrone sulfate transport in HEK-293 transfected hOAT3
HEK-293 WT and hOAT3-V5 transfected cell lines were seeded in 24-well poly-D-lysine coated tissue 
culture plates at a cell density of 2x105 cells/well. After culturing for 2 days, uptake experiments were 
performed at 37°C. The cells were first washed twice with 0.5 ml of Hanks’ Balanced Salt Solution (Sigma 
Aldrich, St. Louis, MO) buffered with 10 mM HEPES (HBSS-HEPES), and pre-incubated in the same solution 
for 10 min. The cells were then pre-incubated in 0.5 ml of HBSS-HEPES solution for 30 min in the absence 
or presence of test compounds (see figure legends) and incubated with 0.3 ml of 100 nM [3H]-ES for 5 min. 
Uptake was stopped by the addition of ice-cold HBSS-HEPES solution, and the cells were washed two times 
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with the same solution. The cells in each well were lysed with 0.5 ml of 1 N NaOH, and neutralized with 0.5 
ml of 1N HCl. Radioactivity was measured after the addition of scintillation fluid and detected by a Tri-Carb™ 
2900 TR Liquid Scintillation Analyzer (Packard, Meriden CT, USA). 
Statistical analysis
Data were expressed as mean ± S.D. Statistical differences were assessed using unpaired, two-tailed 
Student’s t-test in GraphPad Prism (La Jolla, CA). Differences were considered to be significant at *, p<0.05, 
**, p<0.01, ***, p<0.001 versus control.
Results
OAT3 associated with lipid raft domains
To assess whether OAT3 resides in LRD-rich membranes, this insoluble fraction was 
isolated from rat renal cortex, and from a HEK-293 cell line transfected with a V5-tagged 
hOAT3 construct [31], using non-ionic detergent (1% triton X-100) according to a published 
methods [8]. A significant fraction of rOat3 from isolated renal cortex was associated with 
the insoluble (I) fraction, i.e. the LRD-rich fraction, with an apparent rOat3 molecular weight 
of ~150 kDa as detected by Western blot following gel electrophoresis. Additional rOat3 was 
recovered in the non-LRD-rich (S) fraction at a slightly lower molecular weight of ~130 kDa 
(Fig. 1A). LRD-associated cytoskeletal proteins, myosin and β-actin were also present in the 
insoluble fraction. Cav1, an integral protein marker for caveolae-type LRD membrane that had 
been shown previously to interact with Oat3 [18], was predominantly expressed in the LRD-
rich fraction. Myosin was present in LRD-rich fraction, but was also expressed in cytosolic 
fraction. β-actin was present in both LRD- and non-LRD-rich fractions from rat renal cortical 
tissue (Fig. 1A). LRD from hOAT3 expressing HEK-293 cells were also detergent extracted 
and separated by SDS-PAGE. As shown in the Western blot in Figure 1B, human OAT3 was 
found mainly in an insoluble (I) fraction, as was Cav1, indicating the association of OAT3 and 
LRD-rich membrane was similar to that observed for rOat3 isolated from rat renal cortex. 
Next, the HEK-293 expressed hOAT3 cell extract was treated with KI, previously shown to 
disrupt cytoskeletal protein association with LRD [8]. Similar to myosin, when cytoskeletal 
protein localization in the LRD-rich fraction was disrupted by KI treatment, hOAT3 and Cav1 
were re-distributed to soluble (S) and cytoplasmic fractions (Fig. 1B), suggesting that hOAT3 
was associated with LRD-rich membrane and this association was lost upon disruption of 
the cytoskeleton. 
Fig. 1. Distribution of human and rat 
Oat3 in cellular or tissue fractions. (A) 
Western blot detection of rOat3 as well 
as other cytoskeletal or LRD associated 
proteins in three cellular fractions 
or rat renal cortex. Fractions are 
designated: Insoluble (I), Soluble (S) 
and Cytosolic (C) (B) Relative presence 
of hOAT3, Cav1 and myosin in cellular 
fractions (using fraction designations 
described in 1A) from HEK-293 cells. 
Two additional fractions were probed 
for hOAT3, Cav1 and myosin quantities 
after the addition of the cytoskeletal 
disruptor; KI was added (shown as S 
+ KI and I + KI). Representative data 
from one of at least three separate 
experiments is shown. 
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Co-localization of Oat3 and raft-associated proteins
It was previously shown that Cav1 co-localized with rOat3 [18]. Therefore, 
immunofluorescence staining of anti-V5 tag for hOAT3, Cav1, myosin, and β-actin was 
conducted in the hOAT3-V5 expressing cells. As shown in Figure 2, hOAT3-V5 was mainly 
localized in the plasma membrane. There was also minor amorphous distribution within 
Fig. 2. Human OAT3 and LRD associated proteins co-localized on the plasma membrane of HEK-293 cells. 
HEK-293 cells transfected with hOAT3-V5 tag were seeded, fixed, permeabilized and stained with a primary 
antibody against the V5 tag (A, D, G). Additional LRD proteins were stained using antibodies against myosin 
(B), β-actin (E) and Cav1 (H). Localization was probed with either anti-mouse and/or anti-rabbit fluorescent 
secondary antibody by laser scanning confocal microscopy. Images C, F, and I were overlay images of A-B, 
D-E, and G-H, respectively. Representative data from one of at least three separate experiments is shown. 
Fig. 3. Effect of cytoskeletal disruptors on ES uptake 
mediated by Oat3. (A) Rat renal cortical slices were 
pre-incubated with buffer or with buffer containing 
50 µM cycloheximide, 50 µg/ml brefeldin A (BFA), 
50 µM latrunculin A (LTA), and 1 µM okadaic acid 
(OA) for 30 min. [3H]-ES at 100 nM was subsequently 
added and slices were incubated for 30 min at room 
temperature. Uptake of [3H]-ES was measured, and 
tissue to medium ratios (T/M) were determined 
as described in the experimental section. Each 
experiment was conducted three times from 3-4 
animals. (B) HEK-293 cells stably expressing hOAT3 
were pre-incubated with buffer or buffer containing 
test compounds as mentioned above in Figure 3A 
for 30 min. Uptake of [3H]-ES was determined after 
5 min and is shown as pmol/min/mg protein. Each 
experiment was conducted three times from 3-4 
animals. *p<0.05 or ***p<0.001 indicates significant 
differences from the slices or HEK-293 expressed 
hOAT3 cells incubated with cytoskeletal disruptors 
or protein trafficking inhibitors versus with buffer 
alone. WT: wild type HEK-293 cells.
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the intracellular compartment (Fig. 2A, D, G). The expression of the cytoskeletal markers, 
myosin (Fig. 2B) and β-actin (Fig. 2E), was seen throughout the cells; whereas, LRD marker, 
Cav1 (Fig. 2H), was highly expressed on the plasma membrane. Finally, as shown in the 
overlays, Cav1 and hOAT3 were co-localized, consistent with hOAT3 resides in caveolae-LRD 
(Fig. 2C, F, I, arrows). 
Lipid raft-associated cytoskeleton is important for OAT3 function 
As seen in Figures 1 and 2, a significant portion of both human and rat Oat3 resided 
in caveolar-type LRD-rich fraction. Since the cytoskeleton is an important component 
of functional LRD [12, 13], we assessed the importance of cytoskeleton proteins for Oat3 
transport using both rat renal cortical slices and hOAT3-expressing HEK-293 cells. Rat Oat3 
function was significantly reduced after the slices were pre-incubated with cycloheximide, 
a protein trafficking inhibitor (Fig. 3A). Brefeldin A (vesicle transport inhibitor), latrunculin 
A (actin depolymerizer), and okadaic acid (stimulate caveolae internalization), and a high 
concentration of myosin light chain kinase inhibitor 7 (100 µM, data not shown) also reduced 
ES transport, but these effects did not reach statistical significance (Fig. 3A). In hOAT3-
expressing HEK-293 cells, pre-treatment with cycloheximide, brefeldin A, and latrunculin A 
for 30 min significantly inhibited ES uptake; whereas, okadaic acid and cytochalasin D (50 
mg/ml, data not shown) did not change hOAT3 activity (Fig. 3B). These findings indicated 
that Oat3 function was reduced upon disruption of the cytoskeleton. 
Fig. 4. Effect of cholesterol depletion on the 
transport of substrates by rOat3 and rOcts. (A) To 
test the function of rOat3, rat renal cortical slices 
were pre-incubated with buffer or with buffer 
containing 1, 5 or 10 mM MβCD or 10 mM α-CD 
for 30 min. Subsequently, the tissue slices were 
treated with 100 nM [3H]-ES for 30 additional min. 
(B) To test the function of rOcts, rat renal cortical 
slices were incubated with buffer or with buffer 
containing 1, 5 or 10 mM MβCD or 10 mM α-CD for 
30 min. Tissue slices were then incubated in the 
presence of the radiolabeled OCT substrate, [3H]-
TEA, at a concentration of 10 µM for 30 min. (C) To 
test tetra-pentylammomium (TPeA)-sensitive MPP+ 
uptake mediated by rOcts, rat renal cortical slices 
were incubated with buffer alone or with buffer 
containing 1, 5 or 10 mM MβCD for 30 min (left 
panel). Renal tissue slices were then incubated in 
the presence or absence of 100 µM (middle panel) 
or 1 mM (right panel) of TPeA, and all samples were 
subsequently incubated in buffer containing 1 nM of 
[3H]-MPP+ for 30 min. The radiolabeled substrates 
were measured and calculated as tissue to medium 
ratios (T/M), were determined as described in 
the experimental section. Each experiment was 
conducted from separate animals (n = 3-5). *p<0.05, 
**p<0.01 or ***p<0.001 indicates significant 
differences from the slices incubated with buffer 
alone.
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Cholesterol depletion by methyl-β-cyclodextrin (MβCD) specifically impaired Oat3 function 
mediated ES transport 
To determine the role of the membrane lipid environment on Oat3 transport, rat cortical 
slices were pre-treated with three concentrations of the cholesterol depleting agent, methyl-
β-cyclodextrin (MβCD), and uptake of 100 nM [3H]-ES uptake was measured. As shown in 
Figure 4A, 5 and 10 mM MβCD significantly reduced ES uptake, while 1 mM MβCD had a 
little effect. Moreover, α-cyclodextrin (α-CD), an analog of MβCD ineffective in cholesterol 
depletion, did not significantly alter ES uptake at 10 mM. Together these data indicate that 
basal Oat3 transport requires the presence of cholesterol-rich LRD. 
As a control to assess the general toxic effects of these agents on rat renal cortical slices, 
we examined their effects on organic cation transport under identical conditions. As shown 
in Figure 4B, the uptake of 10 µM [3H]-TEA, a well transported substrate for organic cation 
transporters (Octs), was not significantly altered. We also addressed the impact of cholesterol 
depletion on [3H]-MPP+ substrate and used a potent Octs inhibitor, tetrapentylammonium 
(TPeA) to represent TPeA-sensitive Oct transport. As shown in Figure 4C, 1, 5, and 10 mM 
MβCD treatment significantly reduced [3H]-MPP+ uptake at the same extent (left panel). In 
contrast, neither 100 µM nor 1 mM of TPeA-sensitive MPP+ uptake had shown the effect 
of cholesterol depletion by MβCD mediated by rOcts (middle and right panels). Hence, it 
appeared that the integrity of membrane lipid, particularly LRD-rich membrane, has a high 
impact for Oat3 transport of substrates, but not for Octs transport of substrates. 
The observed decrease in Oat3 transport following manipulation of LRD integrity 
(Figs. 3 and 4) could be due to a decrease in transporter activity or a reduction in its surface 
expression, e.g. via altered trafficking to and from the membrane. In Figure 5A, as in Figure 
1, rOat3 was mainly expressed in LRD-rich (I) fraction along with myosin, β-actin and 
Cav1 under control conditions. In addition, rOat3 was also seen in non-LRD-rich (S) and, 
to a lesser extent, in the cytoplasmic (C) fractions. After 10 mM MβCD exposure to deplete 
membrane cholesterol, rOat3 associated with the LRD-rich membranes was significantly 
decreased, rOat3 in non-LRD-rich fraction was unchanged, and cytosolic rOat3 was much 
higher. Detection of rOat3 bands in control and MβCD treated samples was quantitated 
by densitometry. The amount of rOat3 in each fraction was normalized by the amount of 
Fig. 5. Effect of cholesterol depletion on the 
expression of rOat3 and LRD associated proteins. 
(A) Rat renal cortical slices were pre-incubated in 
the presence of buffer or with buffer containing 
10 mM MβCD for 30 min. Three tissue fractions 
were prepared as insoluble (I, the LRD-rich 
membrane region), soluble (S, the non-LRD-rich 
membrane region) and cytosolic (C). Following gel 
electrophoresis and Western blotting, the relative 
expression of proteins in each fraction was observed 
using antibodies against rOat3 and LRD associated 
proteins as described in the experimental section. 
Experiments were conducted for three times 
and a representative Western blot is shown. (B) 
The relative abundance of rOat3 and β-actin in 
each fraction and treatment was quantified with 
densitometry. The amount of rOat3 in control 
and MβCD treated samples was normalized by 
the amount of β-actin present. Mean results from 
three separate experiments appear as a ratio of 
the respective densities (rOat3/β-actin). *p<0.05 
indicates significant differences in rOat3 protein 
expression in the presence of 10 mM MβCD.
D
ow
nl
oa
de
d 
by
: 
A
pp
al
ac
hi
an
 S
ta
te
 U
ni
ve
rs
ity
   
   
   
   
   
   
   
   
   
19
8.
86
.8
.2
 -
 4
/2
2/
20
16
 3
:1
9:
38
 P
M
Cell Physiol Biochem 2013;31:565-578
DOI: 10.1159/000350077
Published online: April 26, 2013
© 2013 S. Karger AG, Basel
www.karger.com/cpb 573
Srimaroeng et al.: Lipid Raft Domains Regulate Oat3 Expression and Function
Cellular Physiology 
and Biochemistry
β-actin present in each respective fraction as shown in Figure 5B. The presence of 10 mM 
MβCD induced cholesterol dependent redistribution of rOat3 into cytosolic pool (Fig. 5B). 
However, β-actin and myosin distributions were unaffected by MβCD. Hence, this data 
indicated that LRD-rich membrane integrity was important for basal rOat3 function through 
the surface expression of rOat3. 
Insulin stimulated ES transport mediated by Oat3 was abolished after removing membrane 
cholesterol 
To determine whether the effect of cholesterol depletion had altered regulation of Oat3, 
we examined its effect on insulin-mediated stimulation of Oat3 activity. We had previously 
shown that insulin stimulated Oat3 function through PKCζ activation [32]. As shown above, 
10 mM MβCD significantly reduced rOat3 expression and function, but 1 mM MβCD did 
not (Figs. 4A and 5A). Likewise, 30 min incubation of 1 mM MβCD did not change rOat3 
expression in LRD-rich fraction (Fig. 6A). However, insulin mediated up-regulated rOat3 
function was completely blocked by 1 mM MβCD; whereas, 1 mM α-CD did not prevent the 
stimulatory effect of insulin. Interestingly, the addition of 10 mM MβCD not only abolished 
the insulin effect, but also substantially inhibited rOat3 transport (Fig. 6B). Together, these 
results indicated that LRD-rich membrane have a significant role in rOat3 regulation, 
probably through altered trafficking of Oat3 to the plasma membrane. 
Fig. 6. Effect of cholesterol depletion on insulin 
stimulated ES transport by rOat3. (A) Upper panel: 
Rat renal cortical slices were pre-incubated in the 
presence of buffer or with buffer containing 1 mM 
MβCD for 30 min. Three fractions were prepared 
as mentioned above in Figure 5A. Following gel 
electrophoresis and Western blotting, the relative 
expression of rOat3 and β-actin in the LRD-rich 
fraction was observed with antibody detection as 
described in the experimental section. Experiments 
were conducted for three times and a representative 
Western blot is shown. Lower panel: The relative 
abundance of rOat3 and β-actin in the LRD-
rich fraction and treatment was quantified with 
densitometry. The amount of rOat3 in control 
and MβCD treated samples was normalized by 
the amount of β-actin present. Mean results from 
three separate experiments appear as a ratio of the 
respective densities (rOAT3/β-actin). (B) Rat renal 
cortical slices were pre-incubated with buffer, 1 mM 
MβCD, or 1 mM α-CD in the presence or absence 
of 30 µg/ml insulin for 30 min. Subsequently, the 
samples were incubated in 100 nM of [3H]-ES for 30 
min. Uptake of [3H]-ES was measured and tissue to 
medium ratios (T/M), were determined as described 
in the experimental section. Means from three 
separate experiments (n= 3-4 animals) are shown. 
*p<0.05 indicates significant differences from the 
control (tissue slices incubated with buffer followed 
by uptake of ES); #p<0.05, ###p<0.001 indicates 
significant differences from the tissue slices 
incubated with buffer in the presence of insulin 
followed by uptake of ES.
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Discussion
Renal Oat3 is highly expressed in the basolateral membrane of the proximal tubular 
epithelium where it plays a major role in the secretion of anionic metabolites and 
xenobiotics [19]. In the present study, we have examined the role of caveolae-type LRD-rich 
membrane on Oat3 function. Caveolae-type LRD exist in many cell types and are important 
in membrane protein targeting, sorting, signaling cascades, and compartmentalization [32, 
33]. For example, it has been shown that insulin receptors are localized in caveolar domains 
of adipocytes plasma membranes and regulate their ability to transport glucose [34]. 
Moreover, disruption of caveolae-LRD integrity attenuated this transport. Such findings have 
led to the suggestion that perturbation of the structure and composition of LRD contributes 
to development of several human diseases, including cancer, cardiovascular, Alzheimer’s, 
and chronic metabolic diseases [35]. In addition, LRD associated proteins, particularly 
cytoskeletal proteins, are important for membrane protein movement and expression [11, 
36]. Disruption of microtubules and microfilaments by either nocodazole or latrunculin 
A abolished Cav1 vesicle trafficking in CHO expressed Cav1 cells [12], suggesting that 
agents altering LRD and associated structural proteins could affect membrane trafficking, 
localization, and function of transporters expressed there. 
To assess this possibility for renal organic anion transport, we isolated detergent-
resistant membrane domains or LRD-rich fraction from rat renal epithelium and HEK-293 
cells expressing hOAT3 and investigated 1) whether there was any association between 
LRD-rich membranes and Oat3, and 2) the impact of LRD integrity on Oat3 function and 
regulation. As shown in Figures 1 and 2, Oat3 was associated with LRD-rich membranes 
in both rat kidney and hOAT3-expressing HEK-293 cells, as were Cav1 and LRD-associated 
cytoskeletal proteins. The association of Oat3 with LRD-rich membranes was similar to that 
seen for other basolateral renal transporters including NKA and epithelial Na+ channel (ENaC) 
in renal thick ascending limb and distal tubule, respectively [16, 37]. In addition, the apical 
NHE3 was also seen in LRD of renal proximal tubule [15]. Together, these finding indicate 
that Oat3, like other renal transporters, was physically located in LRD-rich membrane. 
However, it should be noted that rOat3 migrated as 150 kDa and 130 kDa, whereas, hOAT3 
was detected at 75 kDa. The basis for this observation remains unclear, but it might be 
indicated the existence of membrane transporter oligomerization and/or membrane protein 
and its partner protein complexes. Previously, the major form of hOAT1 was seen at 360 kDa, 
suggesting that homo-oligomers of hOAT1 were present, since monomeric hOAT1 (∼ 80 kDa) 
was not detected in hOAT1-myc-expressing LLC-K1 cells using gel filtration chromatography 
analysis. Moreover, similar to our finding, 1% triton X-100 did not change oligomeric states 
of hOAT1 [38]. Likewise, in previous studies rOat3 was observed at various molecular 
weights from 50-130 kDa depending on its source, antibody specificity, and treatments [18, 
39, 40]. Our previous study also found rOat3 at 130 kDa associated with PKCζ, a binding 
protein, using co-immunoprecipitation [30]. Since Cav1 (21 kDa), a protein residing in the 
detergent-resistant fraction [32], was also found in rat kidney tissues [18], it is possible that 
an rOat3-Cav1 complex was present in detergent-resistant fraction (at 150 kDa); whereas, 
rOat3 oligomerization (at 130 kDa) exists in the soluble fraction. However, this remains 
speculative at present and the structural nature of rOat3 on the basolateral membrane of the 
kidney needs further investigation. 
As shown in Figure 3, disruption of the integrity of LRD-rich membranes by either 
cytoskeleton disruptors (LTA) or protein trafficking inhibitors (cycloheximide and BFA) 
could interfere both rat and human Oat3 function. These findings were similar to previously 
seen for nocodazole inhibition of organic anion transport in teleost fish proximal tubule [41] 
that resulted, at least in part, from disruption of LRD-rich membrane integrity. Furthermore, 
nocodazole and BFA were suggested to decrease the up-regulation of Oat3 by insulin in rat 
renal cortical slices [30]. This finding is also consistent with the observation that disruption 
of cytoskeletal integrity after prolonged incubation of rat renal slices reduced rOat1 and 3 
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expression and function [42]. Of course, none of these findings preclude other mechanisms 
that may regulate Oat expression and function without interfering with LRD integrity. For 
instance, okadaic acid, a phosphatase inhibitor previously shown to promote caveolae 
internalization [32], was shown to phosphorylate mOat1, resulting in reduced mOat1 
function [43]. Moreover, hOAT1 and hOAT3 mediated transport were decreased through 
the activation of PKC by PMA [29, 44, 45]. However, our current findings indicate that Oat3 
expression and function is at least partly controlled by the integrity of LRD and associated 
cytoskeletal proteins in renal tubular epithelium. 
Since both the structure and function of LRD-rich membrane depend upon the presence 
of cholesterol [1, 2], we examined the effects of cholesterol depletion on Oat3 expression 
and function (Figs. 5 and 6). MβCD was used to extract cholesterol from LRD-rich membrane 
in vitro [14, 46]. As shown in Figure 5, MβCD inhibited ES transport mediated by rOat3 
in a dose-dependent manner, but did not inhibit Oct mediated-TEA transport in the same 
preparation. In addition, MβCD had an inhibitory effect on MPP+ transport, it did not alter 
TPeA-sensitive component mediated by rOcts (Fig. C, middle and right panels). Thus, although 
Oct transporters had previously been observed in LRD fraction from rat kidney homogenate 
using tandem mass spectrometry [16], in contrast to rOat3-mediated ES transport, 
cholesterol depletion had less impact on rOcts-mediated substrate transport. This finding 
parallels previous data showing that MβCD treatment altered NHE3 activity, but not that of 
sodium glucose co-transporter 1 (SGLT1) [15]. Likewise, MβCD affected transport via glycine 
transporter 1, but not via transporter 2 [14]. Treatment of rat renal slices with 5 and 10 mM 
MβCD decreased rOat3 expression in LRD-rich fraction and promoted its redistribution into 
the cytosolic fraction (Fig. 5). A lower dose of MβCD (1 mM) did not significantly alter rOat3 
distribution. A similar dose dependent release of cholesterol had been seen previously in 
fibroblasts (60% and 90% after pre-incubation with 2 and 10 mM of MβCD) [46]. Such a shift 
in expression of transporters from LRD to non-LRD had also been reported for NKA [16] 
and the apical Cl-/HCO3-(OH-) exchanger [47]. Moreover, the mobility of Cav1 was controlled 
by cholesterol content and intact cytoskeleton in Hela cell expressing Cav1 [48]. Similarly, 
our data revealed that Cav1 expression was nearly unchanged in the insoluble fraction, 
in contrast to rOat3 expression under cholesterol disruption (Fig. 5A). However, Cav1 re-
distributed after KI treatment as shown in Fig. 1. Therefore, the actual mobility of Cav1 in 
complex tissues remains uncertain. Taken together, these data clearly indicate that integrity 
of LRD-rich membrane and associated cytoskeletal proteins had a significant impact on basal 
rOat3 localization and function. 
Finally, as shown in Figure 6, cholesterol depletion of LRD-rich membrane also altered 
rOat3 regulation. Specifically, both 1 and 10 mM MβCD completely blunted the stimulatory 
effect of insulin on ES uptake via rOat3. Once again, these results parallel previous reports 
for other pathways. For example, insulin receptors were associated with caveolar rafts, 
and its signaling cascade was attenuated by β-cyclodextrin in isolated adipocytes [34]. 
Likewise, activation of cytosolic SGK1 stimulated ENaC activity, and this effect was abolished 
by MβCD in outside-out macropatches from Xenopus Laevis oocytes [37]. In contrast, the 
inactive cyclodextrin analog, α-CD, which does not effectively extract membrane cholesterol, 
was without effect on either basal function or insulin-stimulated rOat3 up-regulation. 
Interestingly, as shown in Figure 6B, 1 mM MβCD completely abolished rOat3 up-regulation 
without changing basal levels of transport in the absence of insulin, suggesting that this 
agent may prevent trafficking of Oat3 to the membrane at concentrations that do not 
lead to a redistribution of membrane associated Oat3 to the interior of the cell. Certainly, 
previous studies also suggest that LRD may control multiple aspects of signaling and 
compartmentation, e.g., insulin signaling in adipocytes [34], the Src family kinases actions in 
Jurkat cells [13] and MEK-ERK signaling cascade in intact macrophages [10]. 
In summary, we have demonstrated that integrity of LRD and its associated proteins 
may markedly alter Oat3 expression and function in kidney tissue and HEK-293 cells. These 
data suggest that Oat3 is localized in LRD-rich membrane along with cytoskeletal proteins, 
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including β-actin and myosin. Expression and function of Oat3 was inhibited by cholesterol 
depletion of LRD-rich membrane by MβCD or by disruption of cytoskeletal proteins. Moreover, 
LRD-rich membrane disruption had a major impact on regulation of Oat3 function. 
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